Boston Common Asset Management’s AbbVie ABBV Stock Holding History

Boston Common Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,333	Closed	-$1.02M	–	297
2022 Q4	$1.02M	Buy	6,333 +153	+2%	+$23.5K	0.05%	163
2022 Q3	$829K	Buy	6,180 +101	+2%	+$14.5K	0.04%	173
2022 Q2	$931K	Buy	6,079 +534	+10%	+$81.6K	0.05%	176
2022 Q1	$899K	Sell	5,545 -663	-11%	-$96.3K	0.04%	173
2021 Q4	$841K	Buy	6,208 +336	+6%	+$39.7K	0.03%	181
2021 Q3	$633K	Buy	5,872 +39	+0.7%	+$4.46K	0.03%	193
2021 Q2	$657K	Buy	5,833 +400	+7%	+$45K	0.03%	199
2021 Q1	$588K	Buy	5,433 +51	+0.9%	+$5.46K	0.04%	199
2020 Q4	$577K	Buy	+5,382	New	+$517K	0.04%	189

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Boston Common Asset Management's ABBV Position: Q1 2023 in Review

Boston Common Asset Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 6,333 shares — an estimated $1.02M sold.

Boston Common Asset Management first reported a position in ABBV in Q4 2020 and held it in 9 quarters. The position peaked at $1.02M in Q4 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Boston Common Asset Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Boston Common Asset Management sold 6,333 AbbVie shares in Q1 2023, an estimated $1.02M.
Boston Common Asset Management first reported a position in AbbVie in Q4 2020 and held it in 9 quarters.
Boston Common Asset Management's AbbVie position peaked at $1.02M in Q4 2022.
3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Boston Common Asset Management's 13F filing for Q1 2023, filed 17 May 2023.